Enzo Life Sciences Screen-Well FDA v 2.0 Approved Drug Library

Thursday, 14 November, 2013 | Supplied by: United Bioresearch Products Pty Ltd

Enzo Life Sciences Screen-Well FDA v 2.0 Approved Drug Library

Drug repositioning or repurposing can be an important part of any drug discovery program. The Enzo Life Sciences Screen-Well FDA-approved drug library has been revised to provide over 100 more compounds, including recent FDA-approved drugs, making it a complete option for drug repurposing screens.

Being FDA approved and in use in clinics, all of the compounds in the drug library have known and well-characterised bioactivity, safety and bioavailability for diverse targets - properties which could dramatically accelerate drug development and optimisation. Its diverse compounds are approved for cardiovascular, neuropsychological, immunological, oncological and other uses.

The library avoids irrelevant compounds found in similar libraries, such as herbicides, insecticides, sunscreen agents and cytotoxic agents. Comprehensive documentation includes a compound list and SD files with indication and mechanism of action. Many of the compounds included can also be provided as stand-alone compounds for further testing.

The set provides a rich source of bioactives and is claimed to offer the greatest degree of drug likeness available.

Online: www.unitedbioresearch.com.au
Phone: 02 4575 0309
Related Products

ALA Scientific Instruments RuFus cell unroofing system for plasma membrane isolation

ALA Scientific Instruments offers RuFus, a complete and user-friendly system for performing cell...

Lonza plateable mouse hepatocytes

Lonza provides plateable mouse hepatocytes from the four most common research mouse strains,...

PEPperPRINT cLIFT peptide microarray platform

At the core of the technology is a laser-based transfer process that is designed to deposit amino...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd